West Pharmaceutical CFO Birkett to retire; Shane Campbell named segment officer
West Pharmaceutical Services said CFO Bernard Birkett intends to retire later this year and will stay until a successor is found, then advise through December 31, 2025. The company also named Shane Campbell, formerly of Carlisle Companies, as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025, with a $600,000 base salary.
Key points
- Bernard Birkett notified the company on April 22, 2025 of his intention to retire as SVP and CFO later this year; a search for a successor has started
- Birkett will remain in his role until a successor is found, then serve in an advisory role until December 31, 2025
- Shane Campbell joins May 5, 2025 with a $600,000 base salary, a 75% target bonus, a $1,000,000 LTI grant and a $400,000 sign-on RSU award
- Campbell previously was Chief Commercial Officer of Carlisle Companies' Construction Materials business and spent 20 years at DuPont
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.